Aristotle University Of Thessaloniki (AUTH)
Μεταβολές στις χολινεργικές οδούς του κατώτερου ουροποιητικού συστήματος σε ασθενείς με καλοήθη υπερπλασία προστάτη και υπερδραστήρια κύστη
Abstract
dc:descriptionScientific backgroundEven though LUTS, BPH and OAB are clearly causally related, the extent to which they are and the nature of the mechanisms linking them are ill-understood. In conditions of bladder outlet obstruction (BOO), OAB is thought to be the result of detrusor overactivity (DO) generated to overcome the BOO, although alternative mechanisms in the cause of this condition seem likely, as the incidence of LUTS and OAB in elderly women matches that of men, a proportion of men with OAB have no BOO, and 30% of men with both OAB and BOO continue to have symptoms despite correcting the BOO.Aim of the studyTo identify potential effects of antimuscarinics on the prostate as well as on the bladder at both molecular and clinical level in patients with BPE-OAB.MethodsWe recruited non-neurological patients with prostate volume >30ml, predominately storage LUTS, ≥3 urgency episodes per 24h, maximum flow rate ≥10ml/s and post-void residual ≤100ml. Patients were randomized to receive either Tamsulosin or Tamsulosin+Solifenacin. Recruited patients were submitted to transrectal and transvesical ultrasonography, pressure-flow study, PSA test and completed the IPSS, bladder diary and OABq questionnaire at induction and at 6 months. At the end of the study, patients were given the choice of prostatectomy. Bladder and prostate tissue samples were evaluated at gene and proteins expression level of muscarinic (M1, M2, M3), adrenergic (Adra 1a, Adra 1d), androgenic and TRPV1 receptors. End-study changes in questionnaires scores, morphometric prostate parameters (total prostate and adenoma volumes, prostate vascular surface) as measured by TRUS and urodynamic parameters were secondary outcomes. Results A statistical significant difference was noted, in protein expression of M3 receptors in prostates of treatment naïve and asymptomatic men as well as in gene expression men receiving combination therapy. There was no difference in M2 expression while M1 expression was reduced in men receiving tamsulosin. A reduction in total prostate volume (mean: -9.5%) was noted in the combination group, as opposed to an increase in monotherapy group (+9.2%)(p<0.001). Similar changes were reflected in adenoma volume (monotherapy:+17.4% vs. combination:-12.5%, p=0.001) and in vascularity (monotherapy:+149.3% vs. combination:-19.8%, p=0.001). Both treatment regimens improved the IPSS (p=0.001) but monotherapy improved more the voiding subscale (p=0.01) while combination therapy improved the storage (p=0.024). Cystometric capacity improved in the combination group (p<0.001). PVR was increased in the combination group (+34.79%) as opposed to a decrease in the monotherapy group (-17.05%) (p=0.001).Conclusions Results of this pilot study suggest a possible role of M3 receptors in pathophysiologic mechanisms responsible for BPE/OAB. Solifenacin may affect morphometric properties of the prostate, decreasing total prostate and adenoma volume as well as vascularity. Mechanistic studies could clarify whether these reflect a molecular effect of antimuscarinics on the prostate, in parallel with their expected bladder effect.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Sakalis, Vasileios
- Σακαλής, Βασίλειος
Subjects
dc:subject × 10Rights
dc:rights- Statement dc:rights
-
- BY_NC_SA
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45420